ND
Visit Website Products & Services
drug developmentdrugdevelopmentstrokeclinical trialsclinicaltrialspharmaceuticals
Company Description
NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis
Business Contact Information
- Phone
- +1 (416) 603 - 5801
- Fax
- No data
- Website
- http://www.nonoinc.ca
- No data
- Address
- 479 Wellington St W, Toronto, Ontario, M5V 1E7, Canada
Industry & Classification
- Industry Name Level 1
- No data
- Industry Name Level 2
- No data
- Industry Name Level 3
- No data
IndustryNo data
NAICS Codes
No data
SIC Codes
No data
Company Details
- Employees
- 50
- Annual Revenue
- $10.0M
- Established
- No data
- Total Funding
- No data
- Latest Funding
- No data
Related Companies
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com